Sunshine Biopharma, Inc.
SBFM
$1.40
-$0.02-1.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.77M | -1.18M | -2.16M | -1.20M | -494.30K |
| Total Depreciation and Amortization | 72.50K | 64.80K | 65.40K | 64.60K | 50.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.06M | -- | 0.00 | 0.00 | 0.00 |
| Change in Net Operating Assets | -636.90K | -598.90K | -1.31M | -227.80K | -4.13M |
| Cash from Operations | -1.27M | -1.71M | -3.41M | -1.36M | -4.58M |
| Capital Expenditure | -160.00K | -7.50K | -102.60K | -517.00K | -974.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -331.80K | -168.50K | -428.90K | -61.40K | 432.30K |
| Cash from Investing | -491.80K | -176.00K | -531.50K | -578.40K | -542.20K |
| Total Debt Issued | -- | -- | 347.90K | -- | -- |
| Total Debt Repaid | -58.40K | -17.20K | 87.90K | -29.70K | -28.60K |
| Issuance of Common Stock | 3.67M | 355.30K | 1.62M | 1.90M | 0.00 |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.61M | 338.10K | 2.05M | 1.87M | -28.60K |
| Foreign Exchange rate Adjustments | 335.70K | -10.20K | -635.30K | 772.30K | -777.90K |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | -- | 0.00 |
| Net Change in Cash | 2.18M | -1.56M | -2.52M | 698.90K | -5.93M |